4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-003554
Director sold 12,500 shares at $18.25 ($228,125)
- Director acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2023-01-12 | Option exercise | +12,500 | $17.01 | $212,625 | 12,500 | D |
| Brege Laura Director | 2023-01-12 | Sale | −12,500 | $18.25 | $228,125 | 0 | D |
| Derivatives | |||||||
| Brege Laura Director | 2023-01-12 | Option exercise · Stock Option (Right to Buy) | −12,500 | 0 | D | ||
| Open-market sales · 12,500 sh · avg $18.25 · $228,125 | |||||||
Loading xslF345X03/doc4.xml…